Natasha Rivas, vice president of quality and regulatory, and Jose Cruz, director of vector manufacturing at Genezen, explore the difficulties in ensuring cGMP compliance is achieved throughout viral vector production.
Examining best practice production suite design, they also highlight the key safety considerations needed when manufacturing these new therapeutic tools.